Reuss Reviews the Development of LP-300 in Advanced NSCLC

Season 9 Episode 4  ·  Jun 19, 2023, 07:20 PM

Headliner
Share
Subscribe

Dr Reuss discusses the development of LP-300 in advanced NSCLC, the mechanisms of LP-300 that may help synergize with the activity of platinum-based chemotherapy, and its ongoing investigation in the phase 2 HARMONIC trial.

Share
Subscribe
Next
Manana Discusses Systemic Racism in Oncology and Future Steps for Equitable Cancer Care
Top episodes
DeNunzio Describes the Advantages of Proton Beam Therapy in Oncology
by OncLive® On Air
FDA Approval Insights: Amivantamab and Mobocertinib in EGFR Exon 20 Insertion+ NSCLC
by OncLive® On Air
Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1
by OncLive® On Air